Holen Sie sich die Stockscreener-App
5.80
0.17%
-0.010
Schlusskurs vom Vortag:
$5.81
Offen:
$5.825
24-Stunden-Volumen:
7,291
Relative Volume:
0.83
Marktkapitalisierung:
$80.54M
Einnahmen:
$57.94M
Nettoeinkommen (Verlust:
$-2.34M
KGV:
-34.81
EPS:
-0.1666
Netto-Cashflow:
$3.82M
1W Leistung:
-0.51%
1M Leistung:
-3.01%
6M Leistung:
-9.23%
1J Leistung:
-37.57%
1-Tages-Spanne:
$5.80
$5.875
1-Wochen-Bereich:
$5.80
$6.2131
52-Wochen-Spanne:
$5.50
$9.95
Champions Oncology Inc Stock (CSBR) Company Profile
Firmenname
Champions Oncology Inc
Sektor
Branche
Telefon
410-369-0365
Adresse
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
5.80 | 80.68M | 57.94M | -2.34M | 3.82M | -0.1666 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-12 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-11-18 | Eingeleitet | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Aktie (CSBR) Neueste Nachrichten
Avoiding Lag: Real-Time Signals in (CSBR) Movement - Stock Traders Daily
Champions Oncology outlines full year revenue growth and positive adjusted EBITDA targets amid early traction in data business - MSN
Nasdaq Moves: What is the Moat Score of Champions Oncology Inc2026 Price Action Summary & Verified Chart Pattern Signals - baoquankhu1.vn
Trading Action: How does Champions Oncology Inc score in quality rankingsEarnings Risk Summary & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Nasdaq Moves: How correlated is Champions Oncology Inc to the S P5002026 Gainers & Low Volatility Stock Recommendations - baoquankhu1.vn
Guidance Update: Will Champions Oncology Inc benefit from geopolitical trends2026 Snapshot & Verified Entry Point Signals - baoquankhu1.vn
S P Trends: Is Champions Oncology Inc benefiting from innovation trendsMarket Risk Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Champions Oncology Inc (CSBR) Q3 2026 Earnings Call Highlights: Record Services Revenue and ... By GuruFocus - Investing.com Canada
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2026 earnings call transcript - MSN
Champions Oncology reports Q3 revenue of $16.6 million - Investing.com Nigeria
A activityTrade Risk Assessment & Verified Momentum Stock Watchlist - Mfd.ru
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2026 Earnings Call Transcript - Insider Monkey
Discipline and Rules-Based Execution in CSBR Response - Stock Traders Daily
Champions Oncology reports Q3 revenue of $16.6 million By Investing.com - Investing.com Australia
Champions Oncology (CSBR) Earnings Transcript - AOL.com
Champions Oncology (CSBR) Earnings Transcript - The Motley Fool
Champions Oncology, Inc. Q3 2026 Earnings Call Summary - Yahoo Finance
Champions Oncology, Inc. Q3 2026 Financial Report: Balance Sheet, Income Statement, and Key Financial Highlights - Minichart
Earnings call transcript: Champions Oncology Q3 2026 misses EPS forecast, revenue grows - Investing.com
CSBR: Record core study revenue and positive adjusted EBITDA despite lower total revenue year-over-year - TradingView
Barco Announces HDR by Barco is confirmed as a format for THE DEVIL WEARS PRADA 2, THE MANDALORIAN AND GROGU, and TOY STORY 5 – NEWSnet Michigan - michigan.newsnetmedia.com
Champions Oncology earnings missed by $0.04, revenue topped estimates - Investing.com Canada
American Properties Realty, Inc. Leadership Attends NAHB International Builders’ Show in Florida - michigan.newsnetmedia.com
John Lauer, EVP and CCO, Announces Retirement Plans - michigan.newsnetmedia.com
Rising costs push Champions Oncology (NASDAQ: CSBR) from profit to loss - Stock Titan
CHAMPIONS ONCOLOGY ($CSBR) Releases Q3 2026 Earnings - Quiver Quantitative
Champions Oncology Q3 revenue dips 3% - TradingView
CSBR: Record study service revenue and positive adjusted EBITDA achieved, with margin improvement expected - TradingView
Champions Oncology (NASDAQ: CSBR) Q3 revenue flat as margins fall - Stock Titan
Champions Oncology Reports Revenue of $16.6 Million - ACCESS Newswire
Cancer research group hits record $16.6M sales but swings to Q3 loss - Stock Titan
Fund Flows: Is Champions Oncology Inc benefiting from innovation trendsBear Alert & Verified Chart Pattern Signals - baoquankhu1.vn
Tom Brady Retirement Struggle Explains Midlife Male Identity Crisis: New Guide - michigan.newsnetmedia.com
Earnings Scheduled For March 12, 2026 - Benzinga
Epson Robots to Showcase Scalable Retail Automation at Shoptalk Spring 2026 - michigan.newsnetmedia.com
Sir Nick Clegg appointed to Efekta Education Group Advisory Board - michigan.newsnetmedia.com
Momentum Shift: How does Champions Oncology Inc. score in quality rankingsEarnings Recap Report & Low Volatility Stock Recommendations - baoquankhu1.vn
International Women’s Day Highlights 2026: Honoring Women in Oncology - Oncodaily
LCUT Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Can SUPV stock sustain double digit ROEAnalyst Upgrade & AI Powered Market Entry Strategies - Naître et grandir
Aug Decliners: Is Champions Oncology Inc showing insider buyingEarnings Beat & Real-Time Buy Signal Alerts - baoquankhu1.vn
Can Atea Pharmaceuticals Inc stock double in the next year2025 Winners & Losers & Consistent Income Trade Ideas - baoquankhu1.vn
Champions Oncology Inc expected to post earnings of 9 cents a shareEarnings Preview - TradingView
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 12, 2026 - Weatherford Democrat
Cancer research firm Champions Oncology plans March 12 Q3 financial call - Stock Titan
CSBR SEC FilingsChampions Oncolo 10-K, 10-Q, 8-K Forms - Stock Titan
Behavioral Patterns of CSBR and Institutional Flows - Stock Traders Daily
IMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
FGBI PE Ratio & Valuation, Is FGBI Overvalued - Intellectia AI
SFBC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
NOTV Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Finanzdaten der Champions Oncology Inc-Aktie (CSBR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):